BG34-200 Immunotherapy of Advanced Melanoma

BG34-200 Immunotherapy of Advanced Melanoma

High levels of myeloid-derived cells are characteristic of the tumor microenvironment (TME) of advanced melanoma. These cells interact with tumor cells to suppress the development of antitumor immune responses, regulate tumor metastasis, and drive cancer’s resistance to virtually all types of therap...

Full description

Bibliographic Details
Main Authors: Veronique Roche, Victor Sandoval, Zachary Senders, Joshua Lyons, Claire Wolford, Mei Zhang
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
advanced melanoma
immunotherapy
carbohydrate
innate immunity
tumor-draining lymph nodes
combination therapy
Online Access:https://www.mdpi.com/2072-6694/14/23/5911

Internet

https://www.mdpi.com/2072-6694/14/23/5911

Similar Items